Status:
ENROLLING_BY_INVITATION
Validate the Difficulty Scoring System and Develop a Novel Scoring System for Laparoscopic and Robotic Liver Resections
Lead Sponsor:
Methodist Health System
Conditions:
Liver Diseases
Eligibility:
All Genders
18-79 years
Brief Summary
To validate the Iwate difficulty scoring system and Institut Mutualiste Montsouris (IMM) scoring system (Appendix 2) in both laparoscopic and robotic liver resections
Detailed Description
Minimally-invasive liver resections (MILR) are increasingly conducted world-wide today. Several international consensus meetings were convened to enable the safe dissemination of laparoscopic and robo...
Eligibility Criteria
Inclusion
- All consecutive patients operated at a single institution during a fixed period
- Most recent operation date allowed (up till December 31, 2020, to allow three months follow-up).
- All minimally invasive hepatectomy approaches can be included, including lap- assisted (hybrid), hand-assisted, robotic-assisted and pure laparoscopy.
- The data of all patients including those that had repeat liver resections, concomitant surgeries (e.g. colectomies, hilar lymph node dissection, enbloc resections) may be included
- Patients with no "liver tumors" such as recurrent pyogenic cholangitis/ gallbladder may be included
- The site of the "lesion/ pathology" will be considered as the tumor site, size will be considered less than 3 cm unless tumor invades the liver.
Exclusion
- • Patients \< 18 years of age
- Patients with liver transplant living donor hepatectomies
Key Trial Info
Start Date :
July 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 16 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05224739
Start Date
July 16 2021
End Date
November 16 2024
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liver Institute of Methodist Dallas Medical Center
Dallas, Texas, United States, 75203